Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors.

Hines, Dionne M

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors. [electronic resource] - Vascular health and risk management 2018 - 409-418 p. digital

Publication Type: Comparative Study; Journal Article

1178-2048

10.2147/VHRM.S180496 doi


Administrative Claims, Healthcare
Adolescent
Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents--administration & dosage
Atherosclerosis--blood
Biomarkers--blood
Cholesterol, LDL--blood
Databases, Factual
Drug Administration Schedule
Drug Therapy, Combination
Female
Formularies as Topic
Humans
Hyperlipoproteinemia Type II--blood
Male
Medicare--trends
Middle Aged
PCSK9 Inhibitors
Practice Patterns, Physicians'--trends
Proprotein Convertase 9--metabolism
Retrospective Studies
Serine Proteinase Inhibitors--administration & dosage
Time Factors
Treatment Outcome
United States
Young Adult